Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Explore effective ways to save money in just 30 days. Implement these tips and watch your savings grow!
14,250 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Tilray’s pivot to CBD and alcohol sparks questions about profitability and risk. This guide cuts through the hype, of...
A reliable dividend is a powerful tool for building wealth. This high-yield pharma beast offers steady income, a robu...
A specialized REIT with cannabis-related tenants moved higher in today’s session. This article breaks down the factor...
Boyd Group stock since its IPO has posted a meaningful climb. This piece breaks down the factors behind the move, wha...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
A small group of foreign exporters now accounts for the overwhelming majority of shotguns imported into the United St...
A New York Fed tariff study finds most costs fall on U.S. businesses and consumers, prompting Kevin Hassett to demand...
Rumors around PayPal buyouts grab headlines and move markets. Here’s how to separate signal from noise, evaluate pote...
Tesla’s foray into robotics and AI promises upside, but it also introduces new risks for shareholders. This guide bre...
As the energy transition gains pace, nuclear power moves back into the spotlight. This article breaks down two stock ...
Carl Icahn steps back from the activist spotlight as Michael Dell solidifies a long-term playbook for Dell Technologi...